Follow the CG인바이츠 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, CG인바이츠 has published 101 public disclosures. Market capitalisation: €65.4bn. The latest transaction was filed on 6 July 2026 (Purchase). Among the most active insiders: 뉴레이크인바이츠투자. The full history is accessible without an account.
98
Insider Decl.
n/a
Thresholds
€613,429
60 ops.
Buy Volume
n/a
26 ops.
Sell Volume
10Σ signal
Buys €613,429n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,512 of 29,053 companies
9.4
score / 100
Value
12
Quality
7
FCF yld-39%
Earn yld-5.4%
EV/EBITDA·
ROE·
Gross mgn-7.1%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CG인바이츠 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.